Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Currently, there is only one U.S. government-approved treatment available for fatty liver disease, Rezdiffra (resmetirom), ...

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...

T1D Fund Joins Financing Syndicate - - Proceeds to Fund Remainder of Phase 2a 'ZONE' Trial and Nonclinical Development of a Once-Weekly V ...

Protein is a cornerstone nutrient for maintaining overall health, but its significance becomes especially prominent for those ...

In a stunning U-turn, the World Health Organization is gearing up to officially endorse weight-loss drugs to tackle obesity ...

In 2021, 529 million people were living with diabetes worldwide, and an estimated 1·31 billion individuals are projected to ...

FAT jabs like Ozempic are set to get the seal of approval from The World Health Organisation (WHO). This would back the use ...

GLP-1 drugs such as Ozempic and Wegovy have been generating a buzz. Initially developed to treat type 2 diabetes, these drugs are now also recognized ...

CAMBRIDGE, MA, USA I April 30, 2025 I Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced that the first participant has ...